NDC 54771-2332 - Amiglyde-V
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 54771-2332
- Package NDCs from labels
- 54771-2332-1
- Manufacturer
- Zoetis Inc.
- Effective date
- 2020-03-19
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Amiglyde-V - Zoetis Inc. | Zoetis Inc. | 2020-03-19 | PRESCRIPTION ANIMAL DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 54771-2332-1 | Amiglyde-V | 48 mL in 1 VIAL | INJECTION | 48 | 4 | |
| 54771-2332-1 | Amiglyde-V | 1 in 1 CARTON | INJECTION | 1 | 4 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 54771-2332 | AMIGLYDE-V (AMIKACIN SULFATE) INJECTION [ZOETIS INC.] | 4 | 2 package rows | 20200401_e2abecaf-9532-45a0-a284-5697b2aa38f1.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| amikacin sulfate | AMIKACIN SULFATE | Sagent Pharmaceuticals | f260ff2a-76a0-4672-9516-91c344b67890 | 2026-07-27 | Boxed warning, Warnings, Adverse reactions | N6M33094FD |
| Amikacin Sulfate | AMIKACIN SULFATE | Mullan Pharmaceutical Inc. | 840ba25a-d60c-4f0d-a084-71b0c68237df | 2026-01-13 | Boxed warning, Warnings, Adverse reactions | N6M33094FD |
| Amikacin Sulfate | AMIKACIN SULFATE | Qilu Pharmaceutical Co., Ltd. | 20fa61ef-11e2-4d01-82ea-b5412cefaead | 2025-12-10 | Boxed warning, Warnings, Adverse reactions | N6M33094FD |
| Amikacin Sulfate | AMIKACIN SULFATE | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | a43188fa-f228-4acd-8a5d-9a3462034f4b | 2025-06-18 | Boxed warning, Warnings, Adverse reactions | N6M33094FD |
| Amikacin Sulfate | AMIKACIN SULFATE | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 7791d3e1-9287-4f75-b4f0-e5d35cacfd6e | 2024-06-28 | Boxed warning, Warnings, Adverse reactions | N6M33094FD |
| Amikacin Sulfate | AMIKACIN SULFATE | Hikma Pharmaceuticals USA Inc. | 0b56f6df-a05d-4520-8bf0-d7cefe20f6ad | 2024-04-08 | Boxed warning, Warnings, Adverse reactions | N6M33094FD |
| Amikacin Sulfate | AMIKACIN SULFATE | Fresenius Kabi USA, LLC | c0f57839-1c9b-49e5-8c7a-708e2d16495d | 2023-05-31 | Boxed warning, Warnings, Adverse reactions | N6M33094FD |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.